News

Deal Announcements

Cellectar Collects Venture Capital Debt

Monday, August 18, 2014 5:30:00 AM PDT | VentureDeal
   Madison, Wisconsin  --  Biotechnology company Cellectar has received $617,000 in venture capital debt financing.

Cellectar is developing molecules "designed to find, treat and follow malignancies" to deliver radiopharmaceuticals.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Cellectar is still seeking $382,500 in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1